# Safety Assessment of Repeated Administration of TK006 in Patients With Breast Cancer-related Bone Metastases

> **NCT03487055** · PHASE1 · UNKNOWN · sponsor: **Jiangsu T-Mab Biopharma Co.,Ltd** · enrollment: 30 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **BIOLOGICAL:** TK006

## Key facts

- **NCT ID:** NCT03487055
- **Lead sponsor:** Jiangsu T-Mab Biopharma Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-05
- **Primary completion:** 2019-05
- **Final completion:** 2019-05
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2018-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03487055

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03487055, "Safety Assessment of Repeated Administration of TK006 in Patients With Breast Cancer-related Bone Metastases". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03487055. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*